Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL218291 (BCX-1777, Forodesine, Immucillin h, Mundesine, NSC-717904) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as reduction in [3H]ethanolamine incorporation incubated for 18 hrs followed by addition of [3H]ethanolamine and measured after 48 hrs by scintillation counting method | F | 7.2 | pIC50 | 63 | nM | IC50 | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
Purine nucleoside phosphorylase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5648] [UniProtKB: Q8T9Z7] | ||||||||
ChEMBL | Inhibition of Plasmodium falciparum His-tagged PNP assessed as inhibitor constant for enzyme-inhibitor complex formation | B | 7.54 | pKi | 29 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
ChEMBL | Inhibition of Plasmodium falciparum PNP expressed in Escherichia coli BL21(DE3) cells by spectrophotometry | B | 9.07 | pKi | 0.86 | nM | Ki | Eur J Med Chem (2010) 45: 5140-5149 [PMID:20817362] |
ChEMBL | Inhibition of Plasmodium falciparum His-tagged PNP assessed as inhibitor constant for enzyme-inhibitor-substrate complex formation | B | 9.22 | pKi | 0.6 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
purine nucleoside phosphorylase/Purine nucleoside phosphorylase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4338] [GtoPdb: 2841] [UniProtKB: P00491] | ||||||||
ChEMBL | Inhibition of human PNP | B | 10.25 | pKd | 0.06 | nM | Kd | Eur J Med Chem (2010) 45: 5140-5149 [PMID:20817362] |
ChEMBL | Inhibition of human PNP assessed as inhibitor constant for enzyme-inhibitor-substrate complex formation | B | 7.14 | pKi | 72 | nM | Ki | J Med Chem (2019) 62: 8365-8391 [PMID:30964283] |
ChEMBL | Initial binding affinity to human PNP His257Gly mutant | B | 7.96 | pKi | 11 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Initial binding affinity to wild type human PNP | B | 8.48 | pKi | 3.3 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Inhibition of human purine nucleoside phosphorylase; Initial rate. | B | 8.48 | pKi | 3.3 | nM | Ki | J Med Chem (2003) 46: 3412-3423 [PMID:12852771] |
ChEMBL | Binding affinity towards Human Purine Nucleoside Phosphorylase was reported | B | 8.48 | pKi | 3.3 | nM | Ki | J Med Chem (2003) 46: 5271-5276 [PMID:14613329] |
ChEMBL | Inhibition of human PNP activity | B | 8.74 | pKi | 1.8 | nM | Ki | J Med Chem (2006) 49: 6037-6045 [PMID:17004717] |
GtoPdb | - | - | 10.14 | pKi | 0.07 | nM | Ki | Biochemistry (1998) 37: 8615-21 [PMID:9628722] |
ChEMBL | Inhibitory activity of compound against human purine nucleoside phosphorylase (PNP) | B | 10.14 | pKi | 0.07 | nM | Ki | J Med Chem (2003) 46: 155-160 [PMID:12502369] |
ChEMBL | Equilibrium binding affinity to wild type human PNP | B | 10.24 | pKi | 0.06 | nM | Ki | Bioorg Med Chem Lett (2008) 18: 5900-5903 [PMID:18778937] |
ChEMBL | Inhibitory activity of compound against human purine nucleoside phosphorylase (PNP) | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2004) 47: 3275-3281 [PMID:15163207] |
ChEMBL | Inhibition of human PNP by xanthine-oxidase coupled assay | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2009) 52: 1126-1143 [PMID:19170524] |
ChEMBL | Dissociation constant against Human Purine Nucleoside Phosphorylase was reported | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2003) 46: 5271-5276 [PMID:14613329] |
ChEMBL | Inhibition of human PNP using inosine as substrate by xanthine oxidase coupled assay | B | 10.25 | pKi | 0.06 | nM | Ki | Medchemcomm (2018) 9: 1983-1993 [PMID:30627387] |
ChEMBL | Equilibrium dissociation constant determined against human purine nucleoside phosphorylase (PNP) after slow-onset inhibition | B | 10.25 | pKi | 0.06 | nM | Ki | J Med Chem (2003) 46: 3412-3423 [PMID:12852771] |
ChEMBL | Inhibition of human purine nucleoside phosphorylase | B | 7 | pIC50 | 100 | nM | IC50 | Bioorg Med Chem Lett (2009) 19: 2627-2629 [PMID:19386496] |
ChEMBL | Inhibition of human PNP activity | B | 8.46 | pIC50 | 3.5 | nM | IC50 | J Med Chem (2006) 49: 6037-6045 [PMID:17004717] |
ChEMBL | Inhibition of human recombinant PNP | B | 10.22 | pIC50 | 0.06 | nM | IC50 | J Med Chem (2021) 64: 17627-17655 [PMID:34894691] |
Purine nucleoside phosphorylase in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2935] [UniProtKB: P55859] | ||||||||
ChEMBL | Binding affinity to calf recombinant PNP expressed in Escherichia coli BL21 (DE3) by isothermal titration calorimetry | B | 10.64 | pKd | 0.02 | nM | Kd | Bioorg Med Chem (2012) 20: 6758-6769 [PMID:23040896] |
ChEMBL | Inhibition of calf spleen PNP assessed as inhibition of 7-methylguanosine phosphorolysis after 50 mins by spectrophotometry in presence of 50 mM inorganic phosphate | B | 7.39 | pKi | 41 | nM | Ki | Bioorg Med Chem (2010) 18: 2275-2284 [PMID:20189401] |
ChEMBL | Inhibitory activity of compound against bovine purine nucleoside phosphorylase (PNP) | B | 10.64 | pKi | 0.02 | nM | Ki | J Med Chem (2003) 46: 155-160 [PMID:12502369] |
ChEMBL | Inhibition of bovine spleen PNP using inosine as substrate by xanthine oxidase coupled assay | B | 10.64 | pKi | 0.02 | nM | Ki | Medchemcomm (2018) 9: 1983-1993 [PMID:30627387] |
Plasmodium falciparum purine nucleoside phosphorylase in Plasmodium falciparum [GtoPdb: 3077] | ||||||||
GtoPdb | - | - | 9.22 | pKi | 0.6 | nM | Ki | J Biol Chem (2002) 277: 3219-25 [PMID:11707439] |
GtoPdb | Parasite growth inhibition assay | - | 7.46 | pIC50 | 35 | nM | IC50 | J Biol Chem (2002) 277: 3226-31 [PMID:11706018] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]